Results 101 to 110 of about 93,913 (298)

Use of green fluorescent nano-sensors for the determination of furosemide in biological samples and pharmaceutical preparations. [PDF]

BMC Chem, 2023
Abo Zaid MH, El-Enany N, Mostafa AE, Hadad GM, Belal F.   +4 more
europepmc   +1 more source

Applying an Ethical Lens to the Treatment of People With Multiple Sclerosis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The practice of neurology requires an understanding of clinical ethics for decision‐making. In multiple sclerosis (MS) care, there are a wide range of ethical considerations that may arise. These involve shared decision‐making around selection of a disease‐modifying therapy (DMT), risks and benefits of well‐studied medications in comparison to
Methma Udawatta, Farrah J. Mateen
wiley   +1 more source

Spectroscopic strategies for quantitation of varenicline in pharmaceutical preparations and content uniformity testing. [PDF]

R Soc Open Sci, 2022
Ibrahim F, Aboshabana R, Elmansi H.
europepmc   +1 more source

Development of Spectrophotometric method for quantitative determination of dexamethasone in pharmaceutical preparations

, 2023
Rafal Abdulraheem Abdullah, Khalaf F. AL-Samarraee   +1 more
openalex   +2 more sources

Characterization of Clinical Phenotype to Glial Fibrillary Acidic Protein Concentrations in Alexander Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine the concentration of glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and plasma in Alexander disease (AxD) and whether GFAP levels are predictive of disease phenotypes. Methods CSF and plasma were collected (longitudinally when available) from AxD participants and non‐AxD controls.
Amy T. Waldman, Asako Takanohashi, Joshua Y. Joung, Geraldine W. Liu, Kaley Arnold, Amy Pizzino, Walter Faig, Sarah Woidill, Sona Narula, Adeline L. Vanderver   +9 more
wiley   +1 more source

Identification and Selection of Prospective Probiotics for Enhancing Gastrointestinal Digestion: Application in Pharmaceutical Preparations and Dietary Supplements. [PDF]

Nutrients, 2023
Cappello C, Tlais AZA, Acin-Albiac M, Lemos Junior WJF, Pinto D, Filannino P, Rinaldi F, Gobbetti M, Di Cagno R.   +8 more
europepmc   +1 more source

Quantitative determination of Lisinopril Dihydrate in pharmaceutical preparations by direct potentiometriy

, 2020
Stanislav Bozhanov, Miglena Smerikarova, Vania Maslarska   +2 more
openalex   +1 more source

Determination of Vitamin Bi in Pharmaceutical Preparations Using a Lead Ion Selective Electrode and Atomic Absorption Spectroscopy [PDF]

, 1979
Saad S. M. Hassan, M. T. M. Zaki, Mohamed H Eldesouki   +2 more
openalex   +1 more source

Preparation of Nanosized Pharmaceutical Formulations by Dual Centrifugation [PDF]

, 2023
Jonas K. Koehler, Stefanie Schmager, V. Bender, Denise Steiner, Ulrich Massing   +4 more
openalex   +1 more source

Remote Assessment of Ataxia Severity in SCA3 Across Multiple Centers and Time Points

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Spinocerebellar ataxia type 3 (SCA3) is a genetically defined ataxia. The Scale for Assessment and Rating of Ataxia (SARA) is a clinician‐reported outcome that measures ataxia severity at a single time point. In its standard application, SARA fails to capture short‐term fluctuations, limiting its sensitivity in trials.
Marcus Grobe‐Einsler, Vivian Maas, Arian Taheri Amin, Jennifer Faber, Tamara Schaprian, Katharina Hill, Matthis Synofzik, Lisa H. Graf, Heike Jacobi, Manuela Lima, Ana F. Ferreira, Bart P. van de Warrenburg, Ilse H. J. Willemse, Dagmar Timmann, Andreas Thieme, Paola Giunti, Hector Garcia‐Moreno, Magda M. Santana, Jeannette Hübener‐Schmid, Elin H. Davies, Thomas Klockgether   +20 more
wiley   +1 more source